DYAI
Dyadic International Inc
NASDAQ: DYAI · HEALTHCARE · BIOTECHNOLOGY
$0.78
+3.54% today
Updated 2026-04-30
Market cap
$31.34M
P/E ratio
—
P/S ratio
10.14x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$1 – $1
Volume
0.1M
Dyadic International Inc (DYAI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-238.30%
Operating margin
-269.60%
ROE
-397.80%
ROA
-44.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $15.38M | $-10.88M | 26.25% | -69.78% | -70.74% |
| 2007 | $13.28M | — | 8.44% | — | — |
| 2008 | $13.12M | — | 13.82% | — | — |
| 2009 | $21.42M | $5.24M | 73.61% | 40.26% | 24.47% |
| 2010 | $8.44M | — | 25.98% | — | — |
| 2011 | $10.25M | — | 37.82% | — | — |
| 2012 | $15.60M | $1.35M | 51.18% | 10.00% | 8.65% |
| 2013 | $17.13M | $-428050.00 | 43.25% | 3.25% | -2.50% |
| 2014 | $12.52M | $-5.98M | 34.71% | -42.52% | -47.75% |
| 2015 | $315712.00 | $65.79M | 60.72% | -1,154.93% | 20,837.76% |
| 2016 | $592886.00 | $-3.61M | 12.94% | -1,004.45% | -608.67% |
| 2017 | $758420.00 | $-2.14M | 10.31% | -939.70% | -281.61% |
| 2018 | $1.30M | $-5.69M | 20.70% | -586.09% | -439.36% |
| 2019 | $1.68M | $-8.31M | 13.17% | -552.18% | -494.21% |
| 2020 | $1.60M | $-9.33M | 11.05% | -625.85% | -582.13% |
| 2021 | $2.40M | $-13.07M | 19.11% | -612.67% | -543.73% |
| 2022 | $2.93M | $-9.74M | 27.54% | -346.92% | -332.23% |
| 2023 | $2.90M | $-6.80M | 31.84% | -283.90% | -234.42% |
| 2024 | $3.50M | $-5.81M | 65.82% | -168.82% | -166.19% |
| 2025 | $3.09M | $-7.36M | 24.93% | -231.23% | -238.31% |